About the role

Company Overview:

Beam Therapeutics is a biotechnology company committed to establishing the leading, fully integrated platform for precision genetic medicines. To achieve this vision, Beam has assembled a platform with integrated gene editing, delivery and internal manufacturing capabilities. Beam’s suite of gene editing technologies is anchored by base editing, a proprietary technology that is designed to enable precise, predictable and efficient single base changes, at targeted genomic sequences, without making double-stranded breaks in the DNA. This has the potential to enable a wide range of therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.

Beam is preparing to open a state-of-the-art Manufacturing facility located on Davis Drive in RTP, NC and will be looking for Manufacturing and Quality professionals to join our team! Please submit your resume here to be considered for positions that we will be opening in Q4 2022 and throughout 2023. We are looking for fearless innovators who are passionate about helping patients and looking to join a collaborative environment where you will be able to have a direct impact on getting our facility up and running.

Skills & Tags

design

Aplyr's read

Beam Therapeutics pioneers precision genetic medicines with its innovative base editing technology, attracting talent in biotechnology and genetic research.
Synthesized from recent postings & public sources

What's promising

•Beam's proprietary base editing technology shows promise in precision genetic medicine.
•Strong focus on innovation attracts top talent in biotechnology and genetic research.
•Recent expansion in roles indicates growth and investment in diverse expertise.

What to watch

•High reliance on unproven base editing technology could pose risks.
•Intense competition in biotechnology may challenge Beam's market position.
•Regulatory hurdles in genetic medicine could delay product development.

Why Beam Therapeutics

•Beam's base editing technology differentiates it from traditional gene editing.
•Focus on precision genetic medicines sets it apart in the biotech sector.
•Strategic roles in diverse areas highlight its comprehensive approach to innovation.

Aplyr’s read is generated by AI from public sources. Was it useful?